CorFlow Therapeutics AG develops and validates the CoFl system for diagnosing and treating Microvascular Obstruction (MVO) in heart attack patients.

Supira Medical, Inc. is developing the Supira System, a percutaneous ventricular assist device (pVAD) designed to provide hemodynamic support for high-risk percutaneous coronary interventions (HRPCI) and cardiogenic shock (CS) patients.